CMP (Rs) 702 Upside/ (Downside) (%) 42 Bloomberg Ticker. JKCE IN Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3

Similar documents
HOLD ACC. Strong Performance on Better Volume and Firm Realizations. Target Price: Rs1,640. Institutional Equity Research

CMP (Rs) 775 Upside/ (Downside) (%) (1.4) Market Cap. (Rs bn) 11.4 Free Float (%) 35.0 Shares O/S (mn) 14.7

Nestlé India Outlook Hazy; Valuations Prohibitive

CMP* (Rs) 166 Upside/ (Downside) (%) 28 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,361 Free Float (%) 37.7 Shares O/S (mn) 8,245

BUY NCC. An Ordinary Quarterly Performance; Maintain BUY. Target Price: Rs98. Institutional Equity Research. 4QFY17 Result Update May 24, 2017

CMP* (Rs) 417 Upside/ (Downside) (%) 46 Bloomberg Ticker. SUNP IN Market Cap. (Rs bn) 1,001 Free Float (%) 46 Shares O/S (mn) 2399

CMP* (Rs) 336 Upside/ (Downside) (%) 21 Bloomberg Ticker. MOIL IN Market Cap. (Rs bn) 45 Free Float (%) 24 Shares O/S (mn) 133

CMP* (Rs) 242 Upside/ (Downside) (%) 2. Market Cap. (Rs bn) 157 Free Float (%) 65.6 Shares O/S (mn) 630

CMP* (Rs) 208 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) Free Float (%) 65.6 Shares O/S (mn) 630

Titan Company BUY. Back to Value Zone Validate Rating Upgrade. Institutional Equity Research. November 05, Target Price Rs428.

CMP* (Rs) 840 Upside/ (Downside) (%) (2.4) Bloomberg Ticker Market Cap. (Rs bn) 379 Free Float (%) 53 Shares O/S (mn) 451.6

CMP* (Rs) 263 Upside/ (Downside) (%) 7.3. Market Cap. (Rs bn) 635 Free Float (%) 59 Shares O/S (mn) 2,417

CMP (Rs) 326 Upside/ (Downside) (%) 24. Market Cap. (Rs bn) 21.7 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 1,458 Upside/ (Downside) (%) 10 Bloomberg Ticker. ABB IN Market Cap. (Rs bn) 309 Free Float (%) 25 Shares O/S (mn) 212

HOLD. Nestle. Good Performance Irrespective of GST Pangs. Target Price: Rs6,624. Institutional Equity Research. 2QCY17 Result Update July 27,2017

CMP* (Rs) 161 Upside/ (Downside) (%) 19 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,329 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 1,424 Upside/ (Downside) (%) 19 Bloomberg Ticker Market Cap. (Rs bn) 268 Free Float (%) 46 Shares O/S (mn) 188

CMP* (Rs) 205 Upside/ (Downside) (%) 12 Bloomberg Ticker. NACO IN Market Cap. (Rs bn) 29 Free Float (%) 27 Shares O/S (mn) 143

CMP* (Rs) 172 Upside/ (Downside) (%) 11.6 Bloomberg Ticker. NTPC IN Market Cap. (Rs bn) 1,414 Free Float (%) 30.3 Shares O/S (mn) 8,245

CMP* (Rs) 346 Upside/ (Downside) (%) 17. Market Cap. (Rs bn) 23 Free Float (%) 42.0 Shares O/S (mn) 67

CMP* (Rs) 203 Upside/ (Downside) (%) 23. Market Cap. (Rs bn) 116 Free Float (%) 61 Shares O/S (mn) 572

CMP* (Rs) 1,464 Upside/ (Downside) (%) 10. Market Cap. (Rs bn) 91 Free Float (%) 55 Shares O/S (mn) 62

CMP* (Rs) 237 Upside/ (Downside) (%) 29 Bloomberg Ticker. APTY IN Market Cap. (Rs bn) 136 Free Float (%) 55.9 Shares O/S (mn) 509

CMP* (Rs) 1,033 Upside/ (Downside) (%) (0.3) Bloomberg Ticker Market Cap. (Rs bn) 467 Free Float (%) 53 Shares O/S (mn) 452

BUY NTPC. Higher Regulated Equity to Aid Profitability; Maintain BUY. Target Price: Rs192. Institutional Equity Research

CMP* (Rs) 360 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 38 Free Float (%) 76 Shares O/S (mn) 104.5

CMP (Rs) 133 Upside/ (Downside) (%) 35 Bloomberg Ticker. ICEM IN Market Cap. (Rs bn) 41 Free Float (%) 71.6 Shares O/S (mn) 308.1

BUY CDSL. Strong Operating Performance; Maintain BUY. Target Price: Rs435. Institutional Equity Research. 2QFY18 Result Update October 31, 2017

KNR Constructions Robust Performance on Execution Ramp-up

CMP (Rs) 249 Upside/ (Downside) (%) Market Cap. (Rs bn) 25.5 Free Float (%) 29.7 Shares O/S (mn) 102.3

BUY. DCB Bank. Improving Capital Consumption to Aid Returns; Maintain BUY. Target Price: Rs202. Institutional Equity Research

CMP* (Rs) 145 Upside/ (Downside) (%) 32 Bloomberg Ticker BOB IN Market Cap. (Rs bn) 384 Free Float (%) 36 Shares O/S (mn) 2,646

CMP* (Rs) 189 Upside/ (Downside) (%) (1) Bloomberg Ticker PNB IN Market Cap. (Rs bn) 402 Free Float (%) 38 Shares O/S (mn) 2,128

CMP* (Rs) 198 Upside/ (Downside) (%) 12. Market Cap. (Rs bn) 61 Free Float (%) 84 Shares O/S (mn) 308

CMP* (Rs) 289 Upside/ (Downside) (%) 18. Market Cap. (Rs bn) 30 Free Float (%) 69 Shares O/S (mn) 105

Sonata Software HOLD. Unimpressive Show; IITS Revenue Disappoints. Institutional Equity Research. February 06, Target Price Rs190.

CMP (Rs) 166 Upside/ (Downside) (%) (1) Bloomberg Ticker Market Cap. (Rs bn) 125 Free Float (%) 37 Shares O/S (mn) 726

CMP* (Rs) 301 Upside/ (Downside) (%) 25. Market Cap. (Rs bn) 19.6 Free Float (%) 26 Shares O/S (mn) 65

Aurobindo Pharma. Institutional Equity Research. Sector - Pharmaceuticals. RSec TradEdge India. March 02, 2017

Jubilant FoodWorks. Institutional Equity Research. Sector - FMCG. RSec TradEdge India. January 17, 2017

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

The India Cements Ltd (ICEM IN) Volumes consistency maintained, confident of regaining pricing power

KEC International. Recovering from a weak phase. Institutional Equity Research. Order inflow traction remains intact

ACC BUY. Performance Highlights. CMP `1,397 Target Price `1,630. 3QCY2015 Result Update Cement

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Ramco Cement. Rating: Target price: EPS: Rating CMP. Target BUY. Rs.415. Rs. 360

Visaka Industries Ltd

Ambuja Cements ACCUMULATE. Performance Highlights. CMP Target Price `207 `233. 3QCY2015 Result Update Cement. Quarterly results (Standalone)

Fineotex Chemical Ltd

Institutional Equities

Balkrishna Industries

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Blue Star Ltd BUY. Performance Update. CMP Target Price `703 `867. 1QFY2019 Result Update Cons. Durable. 3-year price chart.

Transport Corporation of India Ltd.

GMM Pfaudler Limited BUY. Performance Update CMP. `945 Target Price ` QFY2019 Result Update Industrial Machinery. Investment Period 12 Months

Near-term pressure, but long-term outlook positive

Rallis India SELL. Performance Highlights. `231 Target Price 189 CMP. 2QFY2018 Result Update Agrichemical. Investment Period 12 months

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

Inox Wind BUY. Performance Highlights. CMP Target Price `242 `286. 4QFY2016 Result Update Capital Goods. 3 year price chart

Amber Enterprises India Ltd

Dalmia Bharat Enterprises

Quick take. Ruchira Papers Ltd. BUY. Creating value through paper. Target Price. Investment Period 12 Months. 3 year daily price chart.

Goodyear India ACCUMULATE. Performance Highlights. CMP Target Price `326 `374. 1QCY2012 Result Update Tyres. Key financials

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

EBITDA 5,076 3, , EBITDA

Strides Arcolab. Inline 4Q, recent acquisitions to deepen asset growth. Institutional Equity Research. Strides Arcolab. Pharmaceuticals India

Ambuja Cements NEUTRAL. Performance Highlights CMP. `184 Target Price - 2QCY2012 Result Update Cement. Quarterly results (Standalone)

KDDL (KDDL IN) In expansion mode

TTK Prestige Ltd. Result Highlights. Revenue growth of 41% YoY, shows no slowdown yet. OPM at ~15.8%; in line with our estimate

KEC International Ltd.

Amara Raja Batteries BUY. Performance Highlights. CMP `1,010 Target Price `1,167. 2QFY2017 Result Update Auto Ancillary. 3-year price chart

Coal India ACCUMULATE. Performance Highlights CMP. `338 Target Price `380. Outlook and valuation. 2QFY2016 Result Update Mining

MRF BUY. Performance Highlights. CMP `9,407 Target Price `11,343. Company Update Automobile. Key financials

All the more bullish, TP upgraded

Transport Corporation of India Ltd.

Vadodara II PPA yet to be signed; TP revised upward to Rs126 on FY19x

Colgate-Palmolive (India)

Tata Steel NEUTRAL. Performance Highlights CMP. `226 Target Price - 2QFY2016 Result Update Steel. Investment Period - 3-year price chart

Key estimate revision. Financial summary. Year FY16E 29, % 3,583 2, FY17E 26, % 3,478 2,

CCL Products BUY. Brewing Steadily. CMP Target Price `300 `360. Initiating Coverage Coffee. January 4, year price chart

Rallis India NEUTRAL. Performance Highlights CMP. `215 Target Price - 3QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

Asian Granito BUY. Performance Highlights CMP. `270 Target Price `351. Outlook and valuation. 3QFY2017 Result Update Ceramics

Gillette India. Institutional Equities. 1QFY18 Result Update

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

Initiating Coverage. Uflex Ltd.

Ambuja Cements NEUTRAL. Performance Highlights CMP. `155 Target Price - 1QCY2011 Result Update Cement. Investment Period - Key financials (Standalone)

BLS International Services

Rallis India NEUTRAL. Performance Highlights CMP. `242 Target Price - 4QFY2017 Result Update Agrichemical. Investment Period - 3-year price chart

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Sonata Software BUY. Laying the Platform for Growth. Institutional Equity Research. December 01, Target Price Rs185.

HOLD. Coal India Ltd Coal RETAIL EQUITY RESEARCH. Uncertainty remains. GEOJIT BNP PARIBAS Research

Hindustan Media Ventures

Colgate Palmolive (CLGT IN) Volume growth revival is the biggest positive

Indian Oil Corporation

Parag Milk Foods BUY. Performance Update CMP. `256 Target Price `330. 2QFY2019 Result Update Dairy Products. Investment Period 12 Months

Ahluwalia Contracts (India)

BUY. NTPC Ltd Power RETAIL EQUITY RESEARCH

Transcription:

Company Update January 08, 2019 Market Cap. (Rs bn) 54 Free Float (%) 42 Shares O/S (mn) 77.3 Capacity Expansion on Track; Ease of Funding Concern Augurs Well We have interacted with the senior management of (JKCE) to understand its current status of business and general financial synergy after QIP, which was mainly done to meet funding requirement (~Rs20bn) for its ongoing capacity programme. Post completion of QIP issue, (JKCE) is set to witness a healthy traction ahead mainly led by ease of concern over possible increase in leverage, decent progress on capacity expansion programme, healthy earnings in subsequent quarters and likely improvement in the UAE operations. We believe that QIP proceed of Rs5.1bn provides necessary capital to JKCE, which will prevent from further leveraging and thereby will aid the Company to save in incremental interest cost. Maintaining our positive view on the stock and upgrading our earnings estimates for forward years, we reiterate our rating on the stock with a revised Target Price of Rs1,000 (earlier Rs820). Share price (%) 1 mth 3 mth 12 mth Absolute performance (1.0) (0.6) (38.6) Relative to Nifty (1.7) (10.1) (39.4) Shareholding Pattern (%) *Dec 18 Sept 18 Promoter 58.1 64.2 Public 41.9 35.8 Note: *RSec Research QIP Bodes Well for JKCE: A successful fund raising of Rs5.1bn through QIP @ Rs696 offers comfort to JKCE s balance-sheet. We note that JKCE was in need to Rs20bn for its ongoing capex programme till FY21E. Further, capex requirement for FY19-FY20E was estimated at ~Rs18bn and considering its operating cash flow generation of Rs10bn (interest adjusted), we believe JKCE will require less debt than earlier estimate. JKCE expects its gross debt to peak out at Rs30bn in FY20E. Promoter s holding post QIP still stands at 58%, which appears to be decent. 1 Year Stock Price Performance 1200 1100 1000 900 Ongoing Expansion As per Schedule: (1) Mangrol integrated unit (single line kiln of 7,500TPD): Plant and machinery order has been finalised and the basic construction work has already started. It is expected to be commissioned by Sept 19. (2) Nimbahera GU (1mnT): The unit is also expected to be commissioned in Sept 19. (3) Split GUs at Aligarh (1.5mnT) & Silvasa (0.7mnT): Lands have been acquired and environment clearance (EC) for Aligarh unit is obtained recently and EC for Silvasa is expected to be obtained in current month. Orders for grinding equipments have been placed too. These units are expected to come on stream by FY20-end. Post completion of ongoing expansion programme, JKCE s clinker and cement capacity will reach at 10mnT and 13.7mnT, respectively. 800 700 600 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Note: * CMP as on January 08, 2019 Oct-18 Nov-18 Dec-18 Jan-19 Outlook & Valuation We believe overhang of likely high debt has eased now with the completion of QIP issue. Further, likely improvement in its grey cement business performance owing to new kiln at Mangrol will result in improvement in its grey cement performance and hence may entail further re-rating of the stock. We increase our EBITDA estimate by ~7% and ~5% for FY19E and FY20E, respectively mainly to factor in recent reduction in fuel and diesel prices. JKCE currently trades at 8.2x and 7.0x EBITDA of FY20E and FY21E, respectively, which is attractive, in our view. Rolling over our earnings estimates to FY21E, we reiterate our recommendation on the stock with an upwardly revised Target Price of Rs1,000 (9x FY21 EBITDA). Key Financials (Rs mn) FY18 FY19E FY20E FY21E Sales 45,426 48,728 53,345 58,601 EBITDA 7,120 7,376 9,381 10,594 PAT 3,419 3,283 4,331 4,830 EPS (Rs) 48.9 42.5 56.1 62.5 DPS (Rs) 8.0 10.0 5.0 5.0 P/E (x) 14.4 16.5 12.5 11.2 P/B (x) 2.3 1.9 1.7 1.5 EV/EBITDA (x) 9.4 9.4 8.2 7.0 RoE (%) 17.0 13.0 14.0 13.8 Divi. Yield (%) 1.1 1.4 0.7 0.7 Source: Company, RSec Research Research Analyst: Binod Modi Contact: 022 3303 4626 Email: binod.modi@relianceada.com 1

Synergies from New Kiln at Mangrol to Aid Grey Cement Performance: Dismal performance of its grey cement division has been a major hindrance for JKCE s valuation re-rating as grey cement unitary EBITDA has been below par compared to its peers. We believe that operating synergies from new Mangrol clinker unit is likely to aid JKCE to save on energy and repair & maintenance costs compared to current vintage units. The Management expects operating cost savings in Rs80-100/tonne range in its Northern units with the optimum utilisation of new 7,500 TPD kiln at Mangrol. We conservatively calculate its grey cement unitary EBITDA to improve from Rs400 in FY18 and Rs360 in 1HFY19 to Rs590 in FY21E. Production Flow from UAE Unit to Southern Market Augurs Well: Lower utilisation and higher fixed cost were the key overhangs on its UAE operation. Notably, JKCE has started catering to the Southern white cement market via shipment from the UAE units from Nov 18 onwards and selling ~4,000tonne per month. JKCE expects the run rate to continue in subsequent quarters as well, which will lead to better utilisation. Average utilisation for the unit stood at 59% in 9MCY18 vs. 61% CY17. We understand that 4,000tonne/month run rate in India can result in improvement in utilisation up to an additional ~7-8% considering the existing production at par. Premium Cement Gaining Traction: JKCE had launched its premium cement JK Super Power in 2QFY19 especially in the Southern markets, which is slowly gaining traction and it expects it to launch the same in the Northern markets in ensuing quarters. While we are not factoring this in our model, we believe this will result in improvement in blended realisation of grey cement with the sizeable increase its volume, going forward. Risks to the View ff Government s failure to revive infrastructure projects. ff A substantial increase in operating cost. 2

Exhibit 1: A Snapshot of Cost/tonne Scenario and Assumption Rs/tonne FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19E FY20E FY21E Volume (Incl White Cement)- mnt 5.5 5.9 6.4 6.2 7.2 7.8 7.9 9.4 9.7 10.4 11.3 Raw Materials 775 832 929 1,033 1,110 1,177 1,148 1,159 1,094 1,091 1,122 Employee Cost 233 239 248 272 282 300 349 347 376 390 403 Power & Fuel 1,014 1,113 1,124 1,094 1,106 949 793 947 1,110 1,100 1,090 Transportation and Stores 1,038 1,005 1,113 1,221 1,223 1,144 1,179 1,315 1,295 1,273 1,276 Others 264 261 288 307 305 298 405 302 368 372 338 Total Operating Cost 3,324 3,450 3,702 3,927 4,027 3,867 3,873 4,070 4,243 4,226 4,230 EBIDTA/tonne (Rs) 488 863 869 586 619 620 813 758 758 904 935 Source: RSec Research Exhibit 2: Revised v/s Old Estimates FY19E FY20E FY21E Old Revised % change Old Revised % change Introduction Grey Cement Realization/tonne- (Rs) 4,018 4,007 (0.3) 4,179 4,134 (1.1) 4,189 Grey- Volume (mnt) 8.42 8.44 0.3 9.22 9.01 (2.3) 9.87 Sales (Rs mn) 48,723 48,728 0.0 54,827 53,345 (2.7) 58,601 EBIDTA (Rs mn) 6,895 7,376 7.0 8,939 9,381 5.0 10,594 EBIDTA margins (%) 14.2 15.1 16.3 17.6 18.1 PAT (Rs mn) 3,156 3,283 4.0 4,002 4,331 8.2 4,830 PAT margins (%) 6.5 6.7 7.3 8.1 8.2 EPS (Rs) 45.1 42.5 (5.9) 57.2 56.1 (2.1) 62.5 Source: RSec Research 3

Profit & Loss Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E Net sales 45,426 48,728 53,345 58,601 % yoy growth 22.7 7.3 9.5 9.9 Total Cost 38,305 41,353 43,963 48,007 Raw Materials Cost 10,888 10,645 11,328 12,708 Employee Costs 3,255 3,655 4,054 4,571 Power & Fuel 8,897 10,797 11,421 12,349 Selling and Distribution 12,349 12,600 13,212 14,457 Other Exp. 2,840 3,576 3,864 3,833 EBITDA 7,120 7,376 9,381 10,594 EBITDA Margin (%) 15.7 15.1 17.6 18.1 Depreciation 1,863 1,951 2,243 2,661 Interest 2,454 2,359 2,632 2,565 Other Income 1,763 1,624 1,680 1,531 Exceptional item 170 - - - PBT 4,398 4,690 6,187 6,900 Tax 979 1,407 1,856 2,070 Net Profit 3,419 3,283 4,331 4,830 YoY Growth (%) 62.2 (4.0) 31.9 11.5 Net Margin (%) 7.5 6.7 8.1 8.2 4

Balance Sheet Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E Shareholders Fund Share Capital 699 773 773 773 Reserve and Surplus 20,775 28,162 32,028 36,393 21,474 28,934 32,800 37,165 Long Term Borrowings 20,697 21,295 24,295 21,295 Deferred Tax Liability (Net) 2,672 2,672 2,672 2,672 Other Long Term Liabilities 2,991 3,141 3,352 3,591 Long Term Provisions 251 269 294 323 26,611 27,378 30,613 27,881 Short Term Borrowings 1,135 1,635 1,835 1,335 Trade Payables 4,136 5,261 5,759 6,327 Other Current Liabilities 6,270 6,769 7,196 7,858 Short Term Provisions 188 203 216 236 11,730 13,869 15,007 15,757 TOTAL 59,814 70,181 78,421 80,803 ASSETS Tangible Assets 35,923 34,973 49,730 52,070 Intangible Assets 44 44 44 44 CWIP 878 6,000 2,000 1,000 Non Current Investments 5,569 4,704 4,704 4,704 Long Term Loans and Advances 501 1,582 1,732 1,902 Other Non Current Assets 1,149 1,312 1,422 1,560 44,065 48,614 59,632 61,279 Current Investments 776 776 776 776 Inventories 5,316 6,008 6,869 7,706 Trade Receivables 1,880 2,403 3,215 3,211 Cash and Cash Equivalent 5,430 9,861 5,172 4,801 Other Current Assets 2,348 2,519 2,757 3,029 15,749 21,567 18,789 19,524 TOTAL 59,814 70,181 78,421 80,803 5

Cash Flow Statement Y/E Mar (Rs mn) FY18 FY19E FY20E FY21E PBT 4,398 4,690 6,187 6,900 Depreciation 1,863 1,951 2,243 2,661 Interests 2,389 2,359 2,632 2,565 Others (276) - - - Operating Profit before WC changes 8,373 8,999 11,061 12,125 Change in Working Capital 548 (990) (1,234) (164) Tax Paid (1,025) (1,407) (1,856) (2,070) Net Cash from Operating activities 7,896 6,603 7,971 9,891 Purchase of FA including capital advances (1,775) (6,122) (13,000) (4,000) Sale of Fixed Assets 575 - - - Purchase of Investments (7,354) 866 - - Sale of Investments 6,207 - - - Others 1,029 - - - Net Cash from Investing activities (1,318) (5,256) (13,000) (4,000) Net Borrowings (2,932) 1,098 3,200 (3,500) Interest paid (2,411) (2,359) (2,632) (2,565) Others (633) (761) (229) (197) Net Cash from Financing activities (5,976) (2,022) 339 (6,261) Net Increase / (decrease) in cash 601 (676) (4,690) (370) Key Ratio Y/E Mar FY18 FY19E FY20E FY21E Valuation Ratio (x) P/E 14.4 16.5 12.5 11.2 P/CEPS 9.3 10.4 8.3 7.2 P/BV 2.3 1.9 1.7 1.5 EV/EBIDTA 9.4 9.4 8.2 7.0 EV/Sales 1.5 1.4 1.4 1.3 EV/tonne (USD) 82 83 85 69 Dividend Payout (%) 16.4 23.5 8.9 8.0 Dividend Yield (%) 1.1 1.4 0.7 0.7 OCF Yield (%) 16.0 12.1 14.7 18.2 Per Share Data (Rs) EPS (Basic) 48.9 42.5 56.1 62.5 EPS (Diluted) 48.9 42.5 56.1 62.5 CEPS 75.5 67.7 85.1 96.9 DPS 8.0 10.0 5.0 5.0 Book Value 307 374 425 481 EBIDTA/tonne (Blended) 758 758 904 935 Returns (%) RoCE 15.8 14.8 15.9 15.9 RoE 17.0 13.0 14.0 13.8 Turnover ratios (x) Asset Turnover (Gross block) 9.2 9.6 7.9 8.1 Inventory (days) 43 45 47 48 Receivables (days) 15 18 22 20 Payables (days) 39 39 39 39 WCC (days) 18 24 30 29 6

Rating History Date Reco CMP TP 09-Nov-18 691 820 31-July-18 768 880 16-May-18 975 1180 7-Feb-18 1054 1235 15-Nov-17 1075 1300 17-Aug-17 1029 1270 17-May-17 1123 1260 6-Feb-17 801 1000 PLEASE CLICK HERE FOR PREVIOUS REPORTS Rating Guides Rating Expected absolute returns (%) over 12 months >10% HOLD -5% to 10% REDUCE >-5% Reliance Securities Limited (RSL), the broking arm of Reliance Capital is one of the India s leading retail broking houses. Reliance Capital is amongst India s leading and most valuable financial services companies in the private sector. Reliance Capital has interests in asset management and mutual funds, life and general insurance, commercial finance, equities and commodities broking, wealth management services, distribution of financial products, private equity, asset reconstruction, proprietary investments and other activities in financial services. The list of associates of RSL is available on the website www.reliancecapital.co.in. RSL is registered as a Research Analyst under SEBI (Research Analyst) Regulations, 2014 General Disclaimers: This Research Report (hereinafter called Report ) is prepared and distributed by RSL for information purposes only. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice for the purpose of purchase or sale of any security, derivatives or any other security through RSL nor any solicitation or offering of any investment /trading opportunity on behalf of the issuer(s) of the respective security(ies) referred to herein. These information / opinions / views are not meant to serve as a professional investment guide for the readers. No action is solicited based upon the information provided herein. Recipients of this Report should rely on information/data arising out of their own investigations. Readers are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments. This Report has been prepared on the basis of publicly available information, internally developed data and other sources believed by RSL to be reliable. RSL or its directors, employees, affiliates or representatives do not assume any responsibility for, or warrant the accuracy, completeness, adequacy and reliability of such information / opinions / views. While due care has been taken to ensure that the disclosures and opinions given are fair and reasonable, none of the directors, employees, affiliates or representatives of RSL shall be liable for any direct, indirect, special, incidental, consequential, punitive or exemplary damages, including lost profits arising in any way whatsoever from the information / opinions / views contained in this Report. Risks: Trading and investment in securities are subject to market risks. There are no assurances or guarantees that the objectives of any of trading / investment in securities will be achieved. The trades/ investments referred to herein may not be suitable to all categories of traders/investors. The names of securities mentioned herein do not in any manner indicate their prospects or returns. The value of securities referred to herein may be adversely affected by the performance or otherwise of the respective issuer companies, changes in the market conditions, micro and macro factors and forces affecting capital markets like interest rate risk, credit risk, liquidity risk and reinvestment risk. Derivative products may also be affected by various risks including but not limited to counter party risk, market risk, valuation risk, liquidity risk and other risks. Besides the price of the underlying asset, volatility, tenor and interest rates may affect the pricing of derivatives. Disclaimers in respect of jurisdiction: The possession, circulation and/or distribution of this Report may be restricted or regulated in certain jurisdictions by appropriate laws. No action has been or will be taken by RSL in any jurisdiction (other than India), where any action for such purpose(s) is required. Accordingly, this Report shall not be possessed, circulated and/or distributed in any such country or jurisdiction unless such action is in compliance with all applicable laws and regulations of such country or jurisdiction. RSL requires such recipient to inform himself about and to observe any restrictions at his own expense, without any liability to RSL. Any dispute arising out of this Report shall be subject to the exclusive jurisdiction of the Courts in India. Disclosure of Interest: The research analysts who have prepared this Report hereby certify that the views /opinions expressed in this Report are their personal independent views/opinions in respect of the securities and their respective issuers. None of RSL, research analysts, or their relatives had any known direct /indirect material conflict of interest including any long/short position(s) in any specific security on which views/opinions have been made in this Report, during its preparation. RSL s Associates may have other potential/material conflict of interest with respect to any recommendation and related information and opinions at the time of publication of research report. RSL, its Associates, the research analysts, or their relatives might have financial interest in the issuer company(ies) of the said securities. RSL or its Associates may have received a compensation from the said issuer company(ies) in last 12 months for the brokerage or non brokerage services.rsl, its Associates, the research analysts or their relatives have not received any compensation or other benefits directly or indirectly from the said issuer company(ies) or any third party in last 12 months in any respect whatsoever for preparation of this report. The research analysts has served as an officer, director or employee of the said issuer company(ies)?: No RSL, its Associates, the research analysts or their relatives holds ownership of 1% or more, in respect of the said issuer company(ies).?: No Copyright: The copyright in this Report belongs exclusively to RSL. This Report shall only be read by those persons to whom it has been delivered. No reprinting, reproduction, copying, distribution of this Report in any manner whatsoever, in whole or in part, is permitted without the prior express written consent of RSL. RSL s activities were neither suspended nor have defaulted with any stock exchange with whom RSL is registered. Further, there does not exist any material adverse order/judgments/strictures assessed by any regulatory, government or public authority or agency or any law enforcing agency in last three years. Further, there does not exist any material enquiry of whatsoever nature instituted or pending against RSL as on the date of this Report. Important These disclaimers, risks and other disclosures must be read in conjunction with the information / opinions / views of which they form part of. RSL CIN: U65990MH2005PLC154052. SEBI registration no. ( Stock Brokers: NSE - INB / INF / INE 231234833; BSE - INB / INF / INE 011234839, Depository Participants: CDSL IN-DP-257-2016 IN-DP- NSDL-363-2013, Research Analyst: INH000002384); AMFI ARN No.29889. 7